Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)
BACKGROUND: Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) remained until recently the molecular genetic abnormality associated with the worst outcome. Hematopoietic stem cell transplant (HSCT) was considered the treatment of choice, however, recent data have indicated that...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Sarja: | Hematology/Oncology and Stem Cell Therapy |
| Linkit: | https://journals.lww.com/10.1016/j.hemonc.2013.03.001 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|